Neovacs S.A. (EPA:ALNEV)

Neovacs Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	0.01	0.57	0.44	0.89	0.04	16.25
Short-Term Investments	0	-	0	-	6.72	16.84
Cash & Short-Term Investments	0.01	0.57	0.44	0.89	6.76	33.09
Cash Growth	-76.27%	31.31%	-50.91%	-86.87%	-79.57%	228.45%
Accounts Receivable	0.42	0.41	0.31	0.57	0.01	0.01
Other Receivables	1.76	1.55	1.65	2.21	1.8	1.59
Receivables	2.19	1.95	1.95	2.78	1.81	1.6
Prepaid Expenses	0.08	0.04	0.08	0.07	0.49	0.05
Other Current Assets	0.07	0.06	0.01	0.08	0.01	0.04
Total Current Assets	2.35	2.63	2.48	3.81	9.07	34.78
Property, Plant & Equipment	5.47	0.24	0.41	0.53	0.51	0.51
Long-Term Investments	13.61	18.64	18.68	41.49	42.33	13.27
Other Intangible Assets	-	0	0	0	0	0
Other Long-Term Assets	0.77	0.67	0.5	3.83	0.89	0
Total Assets	22.2	22.17	22.07	52.56	55.29	48.55

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	2.46	1.87	2.28	1.98	1.93	1.32
Accrued Expenses	0.74	0.71	1.04	0.02	0.04	0.56
Short-Term Debt	0	0	0	0	0	0.01
Current Portion of Long-Term Debt	0.7	0.54	0.23	0.65	-	-
Current Income Taxes Payable	-	-	0.29	0.98	1.4	0.32
Other Current Liabilities	0.02	0.03	0.01	0.08	0.01	0.02
Total Current Liabilities	3.93	3.15	3.84	3.71	3.38	2.22
Long-Term Debt	-	-	-	-	1.2	1.03
Other Long-Term Liabilities	0.46	0.96	0.17	0.01	0.55	1.4
Total Liabilities	4.39	4.11	4.01	3.72	5.13	4.65

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	0.16	0.19	0.17	0.35	0.12	1.99
Additional Paid-In Capital	79.52	79.44	77.57	141.78	139.67	135.12
Retained Earnings	-61.87	-61.57	-60.34	-94.6	-89.63	-93.22
Comprehensive Income & Other	-	-	0.65	1.31	-	-
Shareholders' Equity	17.81	18.06	18.06	48.84	50.17	43.9
Total Liabilities & Equity	22.2	22.17	22.07	52.56	55.29	48.55

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	0.7	0.54	0.23	0.65	1.2	1.03
Net Cash (Debt)	-0.7	0.03	0.21	0.24	5.55	32.06
Net Cash Growth	-	-83.31%	-13.29%	-95.74%	-82.67%	231.12%
Net Cash Per Share	-	-	-	-	0.02	16.10
Working Capital	-1.58	-0.52	-1.37	0.1	5.68	32.55
Tangible Book Value	17.81	18.06	18.06	48.84	50.16	43.9
Machinery	-	-	1.41	1.33	1.25	1.12
Order Backlog	-	-	0.6	0.74	0.73	0.45

Data Source: S&P Global Market Intelligence Last updated: Nov 21, 2025

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Nov 10, 2026

Data Sources Report a data error